No effect of teriparatide on migration in total knee replacement: A randomized controlled trial involving 50 patients
Background and purpose — Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Teriparatide, a recombinant parathyroid hormone (PTH), stimulates osteoblasts and has been suggested to improve cancellous bone healing in humans. This might also be relevant for prosthesis f...
Main Authors: | Håkan Ledin, Lars Good, Torsten Johansson, Per Aspenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-05-01
|
Series: | Acta Orthopaedica |
Online Access: | http://dx.doi.org/10.1080/17453674.2017.1300745 |
Similar Items
-
Denosumab reduces early migration in total knee replacement: A randomized controlled trial involving 50 patients
by: Håkan Ledin, et al.
Published: (2017-05-01) -
Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models
by: Magnus Bernhardsson, et al.
Published: (2018-11-01) -
Single postoperative infusion of zoledronic acid to improve patient-reported outcome after hip or knee replacement: study protocol for a randomised, controlled, double-blinded clinical trial
by: Jonas Ranstam, et al.
Published: (2020-09-01) -
Weekly Injection of Teriparatide for Bone Ingrowth after Cementless Total Knee Arthroplasty
by: Takao Kaneko, et al.
Published: (2016-04-01) -
PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures: A randomized, controlled study of 40 patients
by: Torsten Johansson
Published: (2016-01-01)